248 related articles for article (PubMed ID: 17084829)
1. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene.
Georgieva NI; Boysen G; Upton PB; Jayaraj K; Gold A; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):219-25. PubMed ID: 16860298
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
4. Formation of 1,2:3,4-diepoxybutane-specific hemoglobin adducts in 1,3-butadiene exposed workers.
Boysen G; Georgieva NI; Bordeerat NK; Sram RJ; Vacek P; Albertini RJ; Swenberg JA
Toxicol Sci; 2012 Jan; 125(1):30-40. PubMed ID: 22003190
[TBL] [Abstract][Full Text] [Related]
5. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA
Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624
[TBL] [Abstract][Full Text] [Related]
6. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Boysen G; Georgieva NI; Upton PB; Jayaraj K; Li Y; Walker VE; Swenberg JA
Cancer Res; 2004 Dec; 64(23):8517-20. PubMed ID: 15574756
[TBL] [Abstract][Full Text] [Related]
7. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
8. Exposure profiling of reactive compounds in complex mixtures.
Goel S; Evans-Johnson JA; Georgieva NI; Boysen G
Toxicology; 2013 Nov; 313(2-3):145-150. PubMed ID: 23219592
[TBL] [Abstract][Full Text] [Related]
9. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin adduct levels in rat and mouse treated with 1,2:3,4-diepoxybutane.
Fred C; Kautiainen A; Athanassiadis I; Törnqvist M
Chem Res Toxicol; 2004 Jun; 17(6):785-94. PubMed ID: 15206899
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
[TBL] [Abstract][Full Text] [Related]
12. Ratios of N-(2,3,4-trihydroxybutyl) valine and N-(2-hydroxy-3-butenyl) valine formed hemoglobin adducts in female mice inhalation exposure with 1,3-butadiene.
Lee JH; Kang HS; Han DH
Toxicol Ind Health; 2005 Mar; 21(1-2):15-20. PubMed ID: 15986572
[TBL] [Abstract][Full Text] [Related]
13. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
14. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
15. Adducts of N-terminal valines in hemoglobin with isoprene diepoxide, a metabolite of isoprene.
Fred C; Cantillana T; Henderson AP; Golding BT; Törnqvist M
Rapid Commun Mass Spectrom; 2004; 18(18):2177-84. PubMed ID: 15378724
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin adducts in 1,3-butadiene exposed Czech workers: female-male comparisons.
Vacek PM; Albertini RJ; Sram RJ; Upton P; Swenberg JA
Chem Biol Interact; 2010 Dec; 188(3):668-76. PubMed ID: 20619252
[TBL] [Abstract][Full Text] [Related]
17. A simplified method for detection of N-terminal valine adducts in patients receiving treosulfan.
Boysen G; Shimoni A; Danylesko I; Varda-Bloom N; Nagler A
Rapid Commun Mass Spectrom; 2019 Nov; 33(21):1635-1642. PubMed ID: 31240802
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA
Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry.
Tretyakova NYu ; Chiang SY; Walker VE; Swenberg JA
J Mass Spectrom; 1998 Apr; 33(4):363-76. PubMed ID: 9597770
[TBL] [Abstract][Full Text] [Related]
20. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
